Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
Fierce Biotech
Thursday, May 15, 2025 - 11:02am
tags:
Biohaven, FDA, troriluzole, adcomm, Rare Diseases
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
Clinical Trials Arena
Thursday, May 15, 2025 - 10:59am
tags:
Revolution Medicines, RMC-6236, clinical trials, non-small cell lung cancer
Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug
Fierce Biotech
Thursday, May 15, 2025 - 10:57am
tags:
Pathos AI, Novo Nordisk, Prelude Therapeutics, funding, solid tumors
Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
BioPharma Dive
Thursday, May 15, 2025 - 10:55am
tags:
PBMs, legislation, Senate
Merck KGaA shares slide after outlook cut on tariff, currency risks
MSN/Wall St Journal
Thursday, May 15, 2025 - 10:53am
tags:
Merck KGaA, earnings, tariffs
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns
CBS News
Thursday, May 15, 2025 - 10:47am
tags:
weight loss, obesity, GLP-1 agonists, David Kessler
A new CFO tasked with taking ‘scrappy’ Editas from last year’s layoffs into new gene editing territory
Pharma Voice
Thursday, May 15, 2025 - 10:43am
tags:
Editas Medicine, gene editing, Amy Parison
RA Capital's biotech incubator lays off staffers
Fierce Biotech
Thursday, May 15, 2025 - 10:41am
tags:
RA Capital, biotech, incubators, Raven, layoffs
US health chief Kennedy clashes with lawmakers over vaccine comments
Investing.com
Wednesday, May 14, 2025 - 11:00pm
tags:
Robert F Kennedy Jr., HHS, vaccines, Senate
Sanofi hops on the US investment bandwagon with $20B commitment through 2030
Fierce Pharma
Wednesday, May 14, 2025 - 10:52pm
tags:
Sanofi, drug manufacturing
AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis
Fierce Pharma
Wednesday, May 14, 2025 - 10:50pm
tags:
AbbVie, solid tumors, FDA, Emrelis, advanced non-squamous non-small cell lung cancer
Former FDA head Robert Califf says RFK Jr.’s vaccine rhetoric is ‘doing harm’ to Americans
Stat
Wednesday, May 14, 2025 - 10:48pm
tags:
Robert Califf, HHS, Robert F Kennedy Jr., FDA, vaccines
Bluebird extends deal deadline; Affimed files for insolvency
BioPharma Dive
Wednesday, May 14, 2025 - 10:45pm
tags:
Bluebird Bio, Carlyle, SK Capital, Affimed
Roche to reconsider US investment projects if Trump follows through on pricing order
Fierce Pharma
Wednesday, May 14, 2025 - 10:41pm
tags:
Roche, Donald Trump, most favored nation, drug pricing
AbbVie pays ADARx $335M cash for next-gen siRNA options
Fierce Biotech
Wednesday, May 14, 2025 - 11:20am
tags:
AbbVie, ADARx Pharmaceuticals, siRNA, funding
FDA moves to ban fluoride supplements for kids, removing a key tool for dentists
NPR
Wednesday, May 14, 2025 - 11:18am
tags:
FDA, fluoride, HHS, Robert F Kennedy Jr., dental health
FDA accepts Regenxbio’s application for MPS II gene therapy
World Pharmaceuticals Frontiers
Wednesday, May 14, 2025 - 11:15am
tags:
Regenxbio, FDA, RGX-121, Hunter Syndrome, gene therapy
5 questions on Trump’s plan to lower US drug prices
BioPharma Dive
Wednesday, May 14, 2025 - 10:57am
tags:
Donald Trump, drug pricing, most favored nation
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Fierce Biotech
Wednesday, May 14, 2025 - 10:56am
tags:
Novo Nordisk, obesity, Septerna
Women’s health faces growing headwinds, despite jump in venture investment
BioPharma Dive
Wednesday, May 14, 2025 - 10:54am
tags:
Women's Health, funding, venture capital

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.